新建灭菌小容量注射剂、搽剂车间GMP改造工程
2006.10.14
项目概述 朝阳富祥药业有限公司目前有小容量注射剂批准文号17个,搽剂批准文号1个,将按GMP要求新建小容量注射剂车间、搽剂车间。车间建成并取得GMP认证后,还要进一步增加新品种,增大企业产值和利润,添补朝阳市制药企业没有小容量注射剂和搽剂品种空白。
投资总额 项目投资4,000万元
产品特点 庆大霉素注射液、硫酸小诺霉素注射液、胞磷胆碱钠注射液等17种小容量注射剂深受广大患者好评,年产销量5000万支。酮洛芬搽剂具有较好的疗效和较高的利润率,年产销量达到1000万支(瓶)。公司还将开发阿仑膦酸钠,该品目前是第一个被美国FDA批准用于治疗和预防骨质疏松的非激素类药物。
优势条件 公司于2004年通过GMP认证,并拥有多个产品生产的批准文号。公司现已完成企业转制,拥有一批专业技术人员和熟练工人。
效益预测 年销售收入13,000万元。
企业现状 朝阳富祥药业有限公司位于朝阳市双塔区中山大街二段,占地约80486.4m2,注册资金为1,500万元,固定资产总值10,188万元,现有职工267人,其中专业技术人员103人。朝阳富祥药业有限公司于2004年12月通过GMP认证。2005年生产乙酰螺旋霉素原料药100吨,固体制剂4亿片(丸、粒)。
联系方式
联系单位:辽宁省朝阳市外经贸局
联系电话:0421-2638306,2638308
传真:0421-2622353
E-mail:cywgd@163.com
网址:www.zgcy.gov.cn
The Newly-built Project of GMP Standard Small Volume Sterilization Injection and Liniment Workshop
PROJECT IN BRIEF:Chaoyang Fuxiang Pharmaceutical Co. Ltd owns 17 kinds of registered numbers of approval for small volume injection, one for liniment. A small- volume injection workshop and a liniment workshop will be built according to GMP. When the workshops are built and it is certified with GMP, there will be a further increase of the new varieties, and it can increase enterprise’s output value and profit, and fill in the gap of small-volume injection and liniments in Chaoyang pharmaceutical industry.
TOTAL INVESTMENT:40 million RMB.
PRODUCT CHARACTERISTICS:17 small-volume injections such as: Gentamicin, Micronomicin Sulfate, Citicoline Sodium injection fluid, is well received by the patients. Annual sales can amount to 50 million ampoules. Fetoprotein Liniment with better efficacy and higher profit margins, annual sales of 10 million ampoules. Company will also develop Alendronic Rain Sodium. This product is the first to be approved for the treatment and prevention of osteoporosis as non-hormone drugs by American FDA.
ADVANTAGES OF THE PROJECT:The Company was certified with GMP in 2004, and got many kinds of registered numbers of approval for the variety of products. The company has already finished enterprise transformation. It has a lot of professionals and skilled workers.
PROFITABILITY PREDICTED:sales income of RMBY130 million per year.
CHINISE SPONSOR'S FILE:Chaoyang Fuxiang Pharmaceutical Co. Ltd is located in Section II, Zhongshan Street, Shuangta District. It covers an area of 80486.4㎡, registered capital of RMBY15 million, the total value of RMBY101.88 million in fixed assets, the existing 267 employees, including103 professional and technical personnel. In December 2004, Chaoyang Fuxiang Pharmaceutical Co. Ltd was certified with GMP. 2005 the company produced 100 tons of Acetylspiramycin medicine raw materials and 400 million pieces of solid preparation.
Communicative Ways:Agency: Foreign Trade and Economic Bureau,Chaoyang Liaoning
Tel:0421-2638306,2638308
Fax:0421-2622353
E-mail:cywgd@163.com
Http:www.zgcy.gov.cn
|